Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 942-135-6 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Endpoint summary
Administrative data
Key value for chemical safety assessment
Additional information
Alcohols, C20-30 (even numbered), is a UVCB substance that comprises several linear long chain alcohols, predominantly tetracosan-1-ol (C24), hexacosan-1-ol (C26), and octacosan-1-ol (C28). Together, these substances make up approximately 70% of the composition of Alcohols, C20-30 (even numbered). Other constituents include, to a much lesser extent, secondary long chain alcohols and complex mixtures of long chain carboxylate esters. On this basis, study data, where available, for each of the long chain alcohol constituents has been evaluated and considered together; this is consistent with the Category approach applied for Long Chain Alcohols (LCA) under REACH.
Available data for D-002, a defined mixture of higher aliphatic alcohols (triacontanol, octacosanol, dotriacontrianol, hexacosanol, tetracosanol) isolated from beeswax, has also been considered in this evaluation.
In a conservative approach the most sensitive study result from the constituents of the LCA category have been identified and used to address the endpoint in question.
A key reliable (Klimisch 2) Ames study was conducted with docosan-1-ol in S. typhimurium strains TA 98, TA100, TA1535, TA1537 and TA 1538. This study was conducted following a protocol similar to OECD 471 but with some deviations (e.g. No TA102 or E. coli WP2 uvrA; 2-aminoanthracene only positive control with metabolic activation). This study reported that docosan1-ol was negative in this bacterial mutation assay. Study data from this study was used as read-across data to support the equivalent icosan-1-ol endpoint.
A second key study reported on a reliable (Klimisch 2) in vitro mammalian chromosome aberration test conducted with a protocol very similar to OECD guideline 473 with docosan-1-ol. Docosan-1-ol did not increase the incidence of chromosome aberrations in Chinese hamster V79 cells in the presence or absence of metabolising fraction at concentrations up to 20 µg/ml. There was no evidence of cytotoxicity at this dose level. Data from this study was used as read-across data to support the equivalent endpoint. Another reliable study (Klimisch 1) in vitro mammalian chromosome aberration test using D-002 in human peripheral blood lymphocytes showed no evidence of cytotoxic or genotoxic potential up to a concentration of 5 mg/mL.
In a reliable (Klimisch 2) micronucleus assay conducted according to a procotol similar to OECD 474 the in vivo mutagenicity of docosan-1-ol was assessed. In this study docosan-1-ol did not increase the incidence of micronuclei in mouse bone marrow cells after a single oral gavage dose of up to 500 mg/kg bw. Consequently docosan-1-ol was reported to be negative in this assay. Study data from this study was used as read-across data to support the equivalent endpoint for Nafol 24 -28. Another study (Klimish 1) performed a micronucleus assay similar to OECD 474 on rat bone marrow cells using D-002. The highest treatment group was 625 mg/kg/day for 90-days and showed no signs of genotoxic effects.
On the basis of the genetic toxicity information included as part of this submission and in line with the read-across justification included, Alcohols, C20-30 (even numbered), is not considered to be genotoxic.
Justification for selection of genetic toxicity endpoint
All studies were reliable (Klimish 2) and reported negative results, so no specific study were selected.
Short description of key information:
In vitro:
Gene mutation (Bacterial reverse mutation assay / Ames test): Docosan-1-ol was negative with and without activation in S. typhimurium strains TA 98, TA100, TA1535, TA1537 and TA 1538 (OECD TG 471)
Cytogenicity in mammalian cells: Docosan-1-ol and D-002 was negative with and without activation in Chinese hamster ovary cells (similar to OECD TG 473)
Mutagenicity in mammalian cells: Docosan-1-ol was negative with and without activation in Chinese hamster lung V79 cells (similar to OECD TG 476)
In vivo:
Mouse micronucleus study: Docosan-1-ol was negative in bone marrow (similar to OECD 474)
Rat micronucleus study: D-002 was negative in bone marrow (similar to OECD 474)
Endpoint Conclusion: No adverse effect observed (negative)
Justification for classification or non-classification
These findings do not warrant the classification of Alcohols, C20-30 (even numbered),as genotoxic under the new Regulation (EC) 1272/2008 on classification, labelling and packaging of substances and mixtures (CLP) and under the Directive 67/518/EEC for dangerous substances and Directive 1999/45/EC for preparations.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
